SCHEMBL4187962

SCHEMBL4187962

Cc1nnc(-c2ccc(S(=O)(=O)Nc3cccnc3CNC(C)CC3CCCCC3)cc2)o1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
PKM P14618 1/20 0.36
CCKBR P32239 1/20 0.35
NPSR1 Q6W5P4 3/20 0.35
MAPK1 P28482 3/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 2/20 0.35
ALOX15 P16050 1/20 0.35
LMNA P02545 6/20 0.34
MAPT P10636 4/20 0.34
TP53 P04637 2/20 0.34
POLB P06746 1/20 0.34
RORC P51449 1/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 4/20 0.33
HTT P42858 2/20 0.33
MITF O75030 1/20 0.33
S1PR4 O95977 1/20 0.33
S1PR1 P21453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4196877 0.87 KDM4E (0.48) KDM4EPKMCCKBRNPSR1MAPK1
SCHEMBL4202586 0.87 KDM4E (0.48) KDM4EPKMCCKBRNPSR1MAPK1
SCHEMBL4197777 0.86 KDM4E (0.46) KDM4EPKMCCKBRNPSR1MAPK1
SCHEMBL4192695 0.76 NFKBIA (0.46) KDM4EPKMNPSR1MAPK1TSHR
SCHEMBL4191293 0.73 KDM4E (0.50) KDM4EPKMMAPK1TSHRLMNA
SCHEMBL4194840 0.72 NPY5R (0.38) KDM4ENPSR1HPGDTSHRTP53
SCHEMBL4706166 0.72 GLO1 (0.35) HPGDTSHRLMNAMAPTPOLB
SCHEMBL4194028 0.72 CYP1A2 (0.35) KMT2AMEN1
SCHEMBL4203511 0.72 KDM4E (0.47) KDM4EPKMTSHRLMNAMAPT
SCHEMBL4197224 0.71 KDM4E (0.46) KDM4EPKMTSHRLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 KDM4E 3328/4885PKM 1855/4885CCKBR 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.